CG Invites Co., Ltd. (KOSDAQ:083790)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Invest			863.08M	597.83M	7.86B	-	-
Invest Growth			44.37%	-92.40%	-	-	-
Pharmaceutical Research			18.27B	17.61B	9.81B	-	-
Pharmaceutical Research Growth			3.78%	79.39%	-	-	-
Inter-Sectoral Coordination			-14.26B	-14.45B	-6.58B	-	-
Other			9.41B	18.89B	14.81B	-	-
Other Growth			-50.17%	27.54%	-	-	-
Discontinued Business			-27.69B	-34.32B	-	-	-
Pharmaceutical Manufacturing (Discontinued Business)			18.28B	16.00B	-	-	-
Pharmaceutical Manufacturing (Discontinued Business) Growth			14.23%	-	-	-	-
Pharmaceutical Manufacturing			-	-	16.47B	-	-
Biotechnology			-	-	-	30.22B	14.01B
Biotechnology Growth			-	-	-	115.78%	0.86%
Total			4.88B	4.32B	42.38B	30.22B	14.01B
Total Growth			12.90%	-89.80%	40.21%	115.78%	0.86%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea			4.28B	4.30B	42.31B	29.48B	13.94B
South Korea Growth			-0.45%	-89.83%	43.51%	111.40%	65.94%
Overseas			597.27M	20.40M	70.72M	745.29M	62.17M
Overseas Growth			2827.48%	-71.15%	-90.51%	1098.81%	-98.87%
Total			4.88B	4.32B	42.38B	30.22B	14.01B
Total Growth			12.90%	-89.80%	40.21%	115.78%	0.86%

Source: S&P Global Market Intelligence.